202 related articles for article (PubMed ID: 10091798)
1. p53 protein expression in squamous cell carcinoma of the vulva.
Scheistrøen M; Tropé C; Pettersen EO; Nesland JM
Cancer; 1999 Mar; 85(5):1133-8. PubMed ID: 10091798
[TBL] [Abstract][Full Text] [Related]
2. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
[TBL] [Abstract][Full Text] [Related]
3. Vulvar squamous cell carcinoma. Prognostic factors for local recurrence after primary en bloc radical vulvectomy and bilateral groin dissection.
Fonseca-Moutinho JA; Coelho MC; Silva DP
J Reprod Med; 2000 Aug; 45(8):672-8. PubMed ID: 10986688
[TBL] [Abstract][Full Text] [Related]
4. p53 protein expression in a population-based series of primary vulval squamous cell carcinoma and immediate adjacent field change.
McConnell DT; Miller ID; Parkin DE; Murray GI
Gynecol Oncol; 1997 Dec; 67(3):248-54. PubMed ID: 9441771
[TBL] [Abstract][Full Text] [Related]
5. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
[TBL] [Abstract][Full Text] [Related]
6. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
Lopes A; Bezerra AL; Pinto CA; Serrano SV; de MellO CA; Villa LL
J Urol; 2002 Jul; 168(1):81-6. PubMed ID: 12050497
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva.
Tempfer C; Gitsch G; Haeusler G; Reinthaller A; Koelbl H; Kainz C
Cancer; 1996 Jul; 78(2):273-7. PubMed ID: 8674003
[TBL] [Abstract][Full Text] [Related]
8. p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer.
Eltabbakh GH; Belinson JL; Kennedy AW; Biscotti CV; Casey G; Tubbs RR; Blumenson LE
Cancer; 1997 Sep; 80(5):892-8. PubMed ID: 9307189
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
[TBL] [Abstract][Full Text] [Related]
10. Expression of the adhesion molecule CD44v3 is a prognostic factor in vulvar carcinoma.
Tempfer C; Gitsch G; Hanzal E; Reinthaller A; Koelbl H; Kainz C
Anticancer Res; 1996; 16(4A):2029-31. PubMed ID: 8712738
[TBL] [Abstract][Full Text] [Related]
11. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery.
Zhu Y; Zhou XY; Yao XD; Dai B; Ye DW
BJU Int; 2007 Jul; 100(1):204-8. PubMed ID: 17433031
[TBL] [Abstract][Full Text] [Related]
13. Invasive squamous cell carcinoma of vulva: prognostic significance of clinicopathologic parameters.
Nola M; Blazanovic A; Dotlic S; Morovic A; Tomicic I; Jukic S
Croat Med J; 2005 Jun; 46(3):436-42. PubMed ID: 15861524
[TBL] [Abstract][Full Text] [Related]
14. Recurrent squamous cell carcinoma of the vulva: clinicopathologic determinants identifying low risk patients.
Preti M; Ronco G; Ghiringhello B; Micheletti L
Cancer; 2000 Apr; 88(8):1869-76. PubMed ID: 10760764
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer.
Ichiyoshi Y; Oiwa H; Tomisaki S; Sakaguchi Y; Ohno S; Maehara Y; Sugimachi K
Hepatogastroenterology; 1997; 44(14):546-53. PubMed ID: 9164535
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma.
Takahashi Y; Noguchi T; Takeno S; Kimura Y; Okubo M; Kawahara K
Oncol Rep; 2006 Feb; 15(2):323-8. PubMed ID: 16391849
[TBL] [Abstract][Full Text] [Related]
17. Mutant p53 in patients with invasive cervical cancer stages IB to IIB.
Kainz C; Kohlberger P; Gitsch G; Sliutz G; Breitenecker G; Reinthaller A
Gynecol Oncol; 1995 May; 57(2):212-4. PubMed ID: 7729736
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.
Kim YB; Kim GE; Cho NH; Pyo HR; Shim SJ; Chang SK; Park HC; Suh CO; Park TK; Kim BS
Cancer; 2002 Aug; 95(3):531-9. PubMed ID: 12209745
[TBL] [Abstract][Full Text] [Related]
19. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.
Garcia del Muro X; Condom E; Vigués F; Castellsagué X; Figueras A; Muñoz J; Solá J; Soler T; Capellà G; Germà JR
Cancer; 2004 May; 100(9):1859-67. PubMed ID: 15112266
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of epithelial disorders adjacent to invasive vulvar carcinomas.
Rouzier R; Morice P; Haie-Meder C; Lhomme C; Avril MF; Duvillard P; Castaigne D
Gynecol Oncol; 2001 Jun; 81(3):414-9. PubMed ID: 11371131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
